ACMI

defunct

About

Defunct Company

Areas of Focus

Categories

Terminally AcquiredBankrupt, Merged, Sold, Renamed or Otherwise Defunct

Clinical Trials (1)

Total Trials

1

As Lead Sponsor

0

As Collaborator

1

Total Enrollment

231

By Phase

PHASE2: 1

By Status

COMPLETED: 1

Clinical Trials Pipeline1 trial

Early Phase 1

Phase 1

Phase 2

Phase 3

Phase 4

Phase 1/2

Phase 2/3

N/A

Phase

Status

Role

Condition

2015

2016

2017

2018

Today

Hover over trial bars to see details

Recent Trials

NCT02903836Collaborator

Phase II Study of Oral Nafithromycin in CABP

PHASE2Completed

231 participants

Started: Nov 18, 2016 · Completed: Jul 8, 2017

Funding History (12)

DEF 14A

Nov 12, 1998

8-K

Oct 8, 1998

DEFA14A

Oct 3, 1997

DFAN14A

Oct 1, 1997

DEFA14A

Sep 30, 1997

DFAN14A

Sep 23, 1997

DEFA14A

Sep 17, 1997

DFAN14A

Sep 17, 1997

DEF 14A

Sep 11, 1997

DFAN14A

Sep 8, 1997

Related Companies

Gyrus

acquired